SEC Form 4 · accession 0001127602-16-056139
PDS Biotechnology Corp · PDSB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kurt G Conti
Director
Period of report
Jun 21, 2016
Accepted (ET)
Jun 23, 2016 · 9:53 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001472091
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right To Purchase) | $9.34 | Jun 21, 2016 | A | 15,000 | A | Jun 21, 2017 | Jun 21, 2026 | Common Stock | 15,000 | 15,000 | D |